Roadblocks to Appropriate OTC Management of URTIs

Erin Dorval, community assistant professor of pharmacy practice at Palm Beach Atlantic University, discusses how pharmacists overcome the challenges of appropriating OTC management of URTIs.

Erin Dorval, PharmD, community assistant professor of pharmacy practice at Palm Beach Atlantic University, discusses how pharmacists overcome the challenges of appropriating OTC management of URTIs.

This video was filmed at CHPC 2015.

Related Videos
View All
Related Content

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.